Skip to main content
Medical information Clinical review pending

Gynecological Testing

Ovarian Reserve Panel Test

The Ovarian Reserve Panel Test evaluates a woman's fertility potential by measuring key hormones related to ovarian function and reserve. Essential for family planning and fertility assessment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (2 mL minimum) serum from 1 Serum Separator Tube (SST).
Results
Sample Daily by 9 am; Report Same Day. Confirm with the laboratory before booking.
Preparation
Specify the day of the menstrual cycle on the test request form. Confirm with the laboratory before booking.
Test priceKSh 9,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Ovarian Reserve Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Difficulty conceiving
  • ✓Women over 35 years old
  • ✓Irregular menstrual cycles
  • ✓Family history of reproductive issues
  • ✓Considering assisted reproductive technologies
  • ✓Family planning assessment
02

In plain language

What this test helps you understand

Assesses ovarian function and reserve through hormone level measurement (FSH, Estradiol, AMH) to aid in fertility assessment and family planning decisions.
The Ovarian Reserve Panel Test is a vital diagnostic tool for women evaluating their fertility potential. This test measures hormone levels that provide insight into ovarian function and reserve, helping women make informed decisions regarding family planning and reproductive health. This comprehensive test assesses three key hormones: Follicle Stimulating Hormone (FSH), Estradiol, and Anti-Müllerian Hormone (AMH). These hormones play a crucial role in ovulation and overall reproductive health, providing valuable information about a woman's fertility status. Understanding your ovarian reserve is essential for informed family planning decisions, identifying potential fertility issues early, guiding treatment options for infertility, and assessing the need for assisted reproductive technologies. Your test results will provide insights into your ovarian reserve, helping you and your healthcare provider understand your reproductive health better. It is essential to discuss your results with a gynecologist or endocrinologist who can guide you on the next steps based on your individual situation.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationSpecify the day of the menstrual cycle on the test request form. Confirm with the laboratory before booking.
Sample3 mL (2 mL minimum) serum from 1 Serum Separator Tube (SST).
MethodologyEIA, CLIA
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results should be interpreted in conjunction with clinical history and other diagnostic tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test measures three key hormones: Follicle Stimulating Hormone (FSH), Estradiol, and Anti-Müllerian Hormone (AMH) to assess ovarian function and reserve.
Women experiencing difficulty conceiving, those over 35, individuals with irregular cycles, those with a family history of reproductive issues, or those considering fertility treatments may benefit from this test.
The test provides insights into your ovarian reserve, helping you and your doctor understand your fertility status and make informed decisions about family planning.
You will need to specify the day of your menstrual cycle on the test request form. Please confirm any other specific instructions with the laboratory before booking.
Results should be discussed with a healthcare provider, such as a gynecologist or endocrinologist, who can interpret them in the context of your individual health history.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp